Literature DB >> 6272628

6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.

B A Moore, K W Brammer.   

Abstract

UK-38,006, 6 beta-iodopenicillanic acid, was shown to be a potent inhibitor of beta-lactamase enzymes. It potentiated the antibacterial action of ampicillin in vitro against beta-lactamase-producing strains of Staphylococcus aureus, Haemophilus influenzae, Bacteroides fragilis. Neisseria gonorrhoeae, and many Enterobacteriaceae. This ability to synergize with ampicillin was also demonstrated in vivo after oral administration of UK-38,006 to experimentally infected mice. UK-38,006 was also shown to synergize in vitro with other penicillins and cephalosporins against beta-lactamase-producing strains of Escherichia coli, Proteus mirabilis, and Klebsiella species.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272628      PMCID: PMC181695          DOI: 10.1128/AAC.20.3.327

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  A semi-synthetic penicillinase inactivator.

Authors:  S J Cartwright; A F Coulson
Journal:  Nature       Date:  1979-03-22       Impact factor: 49.962

2.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  The interplay of beta-lactamases and intrinsic factors in the resistance of gram-negative bacteria to penicillins and cephalosporins.

Authors:  M H Richmond; N A Curtis
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

4.  Synergy of antibacterial substances by apparently known mechanisms.

Authors:  L D Sabath
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

Review 5.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

6.  Inhibition of Escherichia coli TEM-2 beta-lactamase by the sulfated compounds izumenolide, panosialin and sodium dodecyl sulfate.

Authors:  K Bush; J Freudenberger; R B Sykes
Journal:  J Antibiot (Tokyo)       Date:  1980-12       Impact factor: 2.649

7.  PS-5 inhibition of a beta-lactamase from Proteus vulgaris.

Authors:  K Okamura; M Sakamoto; T Ishikura
Journal:  J Antibiot (Tokyo)       Date:  1980-03       Impact factor: 2.649

8.  Bacampicillin: a new orally well-absorbed derivative of ampicillin.

Authors:  N O Bodin; B Ekström; U Forsgren; L P Jalar; L Magni; C H Ramsay; B Sjöberg
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

9.  Inactivation of Bacillus cereus beta-lactamase I by 6 beta-bromopenicillanic acid: kinetics.

Authors:  M J Loosemore; S A Cohen; R F Pratt
Journal:  Biochemistry       Date:  1980-08-19       Impact factor: 3.162

10.  Phenylpropynal, a specific, irreversible, non-beta-lactam inhibitor of beta-lactamases.

Authors:  D P Schenkein; R F Pratt
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

  10 in total
  6 in total

1.  6-beta-Iodopenicillanate as a probe for the classification of beta-lactamases.

Authors:  F De Meester; J M Frère; S G Waley; S J Cartwright; R Virden; F Lindberg
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

2.  Interaction of beta-iodopenicillanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39.

Authors:  J M Frère; C Dormans; C Duyckaerts; J De Graeve
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

Review 3.  Three decades of the class A beta-lactamase acyl-enzyme.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

4.  Structural basis of the inhibition of class A beta-lactamases and penicillin-binding proteins by 6-beta-iodopenicillanate.

Authors:  Eric Sauvage; Astrid Zervosen; Georges Dive; Raphael Herman; Ana Amoroso; Bernard Joris; Eveline Fonzé; Rex F Pratt; André Luxen; Paulette Charlier; Frédéric Kerff
Journal:  J Am Chem Soc       Date:  2009-10-28       Impact factor: 15.419

5.  Isolation of the membrane-bound 26 000-Mr penicillin-binding protein of Streptomyces strain K15 in the form of a penicillin-sensitive D-alanyl-D-alanine-cleaving transpeptidase.

Authors:  M Nguyen-Distèche; M Leyh-Bouille; J M Ghuysen
Journal:  Biochem J       Date:  1982-10-01       Impact factor: 3.857

Review 6.  Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; D M Richards; R N Brogden; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.